Literature DB >> 1697008

Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.

F J Bot1, L van Eijk, P Schipper, B Backx, B Löwenberg.   

Abstract

The human multilineage hematopoietic growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) induces multipotent, erythroid, and eosinophil colony formation from highly enriched normal bone marrow cells. We have examined the effects of GM-CSF combined with granulocyte-CSF (G-CSF) or macrophage-CSF (M-CSF) on the monolineage granulocytic, eosinophilic, and macrophage progenitor cells (CFU-G, CFU-Eo, and CFU-M) in accessory cell depleted marrow fractions. GM-CSF effects were assessed in direct comparison with those of interleukin-3 (IL-3) plus G-CSF or M-CSF. GM-CSF strongly synergized with G-CSF in the formation of granulocytic colonies with respect to number and size and enhanced the in vitro survival of CFU-G. More immature cells were present in colonies induced by the mixture of GM-CSF and G-CSF than by G-CSF alone. GM-CSF also synergized with M-CSF in the formation of macrophage colonies (number and size). The addition of G-CSF and M-CSF did not influence eosinophil colony formation induced by GM-CSF or IL-3. Experiments directly comparing GM-CSF and IL-3 revealed that the effects of GM-CSF on G and M colony-forming cells were significantly greater than those of IL-3. The potent positive effects between GM-CSF and G-CSF as well as between GM-CSF and M-CSF provide a powerful mechanism of amplification of granulopoiesis and monocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697008

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  Growth factors and hematopoietic recovery.

Authors:  S C Gulati; R Gopal; J B Prowda; S Spanik; M Jain; A Gopal
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

Review 3.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

4.  Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.

Authors:  M J Laughlin; G Kirkpatrick; N Sabiston; W Peters; J Kurtzberg
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

5.  Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Authors:  Juçara Gastaldi Cominal; Maira da Costa Cacemiro; Maria Gabriela Berzoti-Coelho; Illy Enne Gomes Pereira; Fabiani Gai Frantz; Elizabeth Xisto Souto; Dimas Tadeu Covas; Lorena Lobo de Figueiredo-Pontes; Maria Carolina Oliveira; Kelen Cristina Ribeiro Malmegrim; Fabíola Attié de Castro
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

Review 6.  The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis.

Authors:  Irene Mavroudi; Helen A Papadaki
Journal:  ScientificWorldJournal       Date:  2011-10-26

Review 7.  Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.

Authors:  Jian Chen; Hillard M Lazarus; Parastoo B Dahi; Scott Avecilla; Sergio A Giralt
Journal:  Blood Rev       Date:  2020-10-31       Impact factor: 10.626

Review 8.  Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?

Authors:  Whitney D Wallis; Muzaffar H Qazilbash
Journal:  World J Transplant       Date:  2017-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.